Cardiology News

People with narcolepsy were more likely than propensity score-matched people without narcolepsy to develop heart disease, regardless of sleep apnea status, according to a retrospective cohort study.

The prevalence of chronic hypertension during pregnancy doubled in the U.S. since 2008, with no changes in antihypertensive use over the years despite updated clinical guidance on BP control, researchers reported.

Cleveland Clinic has launched a holistic health center focused exclusively on caring for midlife women, addressing a wide range of needs from osteoporosis and breast health to CVD prevention and the menopause transition.

Overreliance on high-sensitivity troponin as the sole assay to diagnose heart attacks has led to a rise in misdiagnosis, which is not benign and burdens the health system and patients with unnecessary and sometimes invasive testing.

A narrative review found no evidence that sodium restriction affects morbidity and mortality in patients with heart failure.

The association between daily alcohol consumption and risk for hypertension is a linear relationship and the strength of the association varied between men and women, researchers reported.

In patients with obesity-driven heart failure with preserved ejection fraction, semaglutide 2.4 mg was associated with more improvement in NYHA functional class compared with placebo, according to new data from the STEP-HFpEF trials.

Because the science underpinning medicine evolves so quickly, it is not uncommon for some doctors to manage patients based on old evidence that is no longer a best practice; this is called clinical inertia.

Almost one-third of adults aged 60 years and older without CVD regularly used aspirin for primary prevention in 2021, contrary to guidance from medical organizations, a study showed.

Teva Pharmaceuticals announced it has launched the first generic version of a GLP-1 receptor agonist in the United States, liraglutide 1.8 mg.